IMS-treatment and Canalis Carpi Syndrome

• Register: ClinicalTrials.gov
• Last refreshed on: 17 October 2012
• Main ID: NCT01102868
• Date of registration: 29/03/2010
• Primary sponsor: Uni Research
• Public title: IMS-treatment and Canalis Carpi Syndrome
• Scientific title: An Randomized Controlled Trial of IMS-treatment Versus Scam for Canalis Carpi Syndrome
• Date of first enrolment: April 2009
• Target sample size: 75
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT01102868
• Study type: Interventional
• Study design: Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Countries of recruitment

Norway

Contacts

• Name: Stein Atle Lie, Professor
• Affiliation: Uni Health, University Research

Key inclusion & exclusion criteria

Inclusion Criteria:

- Canalis Carpi Syndrome verified by ultrasound and clinically

- Both genders

- Age from 18 to 67

Exclusion Criteria:

- Negative neurophysiology result.

- Epilepsy,

- Heart disease,

- Rheumatism

- Unstable angina pectoris,

- Metal -allergy,

- Needle- phobia,

- Infection

- Hemophilia

- Cognitive problems



Age minimum: 18 Years
Age maximum: 67 Years
Gender: Both

Health Condition(s) or Problem(s) studied

Carpal Tunnel Syndrome

Intervention(s)

Device: IMS of the musculus pronator teres

Device: Needle in acupuncture point Li11

Primary Outcome(s)

Diameter of the Nervae medianus in the Carpal Tunnel [Time Frame: End 2011]

Secondary Outcome(s)

Health complaints [Time Frame: End 2011]

Power of the hand grip [Time Frame: End 2011]

Secondary ID(s)

IMS1234

Source(s) of Monetary Support

Please refer to primary and secondary sponsors